FDA Releases Draft Guidance for Evaluating Oxygen Therapeutics as Red Blood Cell Substitutes

Summary

The FDA has made available a draft document outlining criteria for testing the safety and efficacy of oxygen therapeutics as substitutes for red blood cells, with the goal of assessing their risk/benefit ratio in clinical trials.